Skip to content
★ Sign in to follow
QM

Quentin McCubbin

Directeur de la fabrication
Total declarations
9
Company
1
▲ Purchases (1 ops.)
€73k
▼ Sales (6 ops.)
€34k

Latest filing published 07 Jul 2022 for Korro Bio, Inc., €9,802.

Filing timeline

BuySale
Quentin McCubbin

Insider track record

Disclosed buys
1
Disclosed sells
6
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 19 May 2021 · 2001 days ago · €73k
    -87.3%
    Entry US$436.00 · Close at T+365 US$55.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Quentin McCubbin: trading record in brief

Quentin McCubbin, listed as senior executive, appears in our data through filings on Korro Bio, Inc. shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 17 May 2021 to 6 July 2022.

The open-market side counts 1 purchase for €73k alongside 6 sales for €34k. Netting one side against the other leaves €39k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 option exercises. 2022 to date brings no purchases and 6 sales.

The newest entry dates from 7 July 2022: an open-market sale of €9,802, in Korro Bio, Inc. The latest purchase dates back some time: it was published 2,001 days ago, on 19 May 2021. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Quentin McCubbin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    9,985 USD30SEC
    6,569 shares@ US$1.529.2% of flowCommon StockSEC:0001127602-22-019049:1
  • ◇
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    0SEC
    17,500 sharesCommon StockSEC:0001127602-22-019049:0
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    5,592 USD31SEC
    1,584 shares@ US$3.534.6% of flowCommon StockSEC:0001127602-22-006314:1
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    5,463 USD32SEC
    1,411 shares@ US$3.8725.8% of flowCommon StockSEC:0001127602-22-006314:0
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    5,473 USD31SEC
    1,303 shares@ US$4.204.5% of flowCommon StockSEC:0001127602-22-005747:1
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    5,461 USD32SEC
    1,233 shares@ US$4.4295.8% of flowCommon StockSEC:0001127602-22-005747:0
  • ▼
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    5,460 USD31SEC
    1,261 shares@ US$4.334.5% of flowCommon StockSEC:0001127602-22-005334:1
  • ◇
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    0SEC
    17,500 sharesCommon StockSEC:0001127602-22-005334:0
  • ▲
    Chief Manufacturing OfficerExecutivesKorro Bio, Inc.
    88,500 USD19SEC
    10,000 shares@ US$8.8588.3% of flowCommon StockSEC:0001127602-21-017370:0
    Canonical exit: 15 Aug 2021 (T+90)

9 of 9 declarations